In contrast, SNHG12 over-expression activated the MAPK/ERK pathway and rescued MAPK1 silencing in TMZ-resistant GBM cells (Fig. 7e-f and Additional file 11: Figure S6f). The gene discussed is MAPK1; the disease is glioblastoma.